Publications

All HREB Publications

Brinton LA, Lubin JH, Murray MC, Colton T, Hoover RN. Mortality rates among augmentation mammoplasty patients: An update. (pdf) Epidemiology 2006 March;17(2):162-9.
García-Closas M, Egan KM, Newcomb PA et al. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. (pdf) Hum Genet 2006 May;119(4):376-88.
García-Closas M, Brinton LA, Lissowska J et al. Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer 2006 Jul 3;95(1):123-9.
Lissowska J, Brinton LA, Zatonski W et al. Tobacco smoking, NAT2 acetylation genotype and breast cancer risk. Int J Cancer 2006 May 17.
Falk RT, Fears TR, Xu X et al. Urinary estrogen metabolites and their ratio among Asian American women. (pdf) Cancer Epidemiol Biomarkers Prev 2005 January;14(1):221-6.

Cervical Cancer: Screening and Testing
Cervical Cancer Home Page
Task Force Announces New Cervical Cancer Screening Guidelines 01/22/2003.
Human Papillomaviruses and Cancer
Hildesheim A, Berrington de González A. Etiology and prevention of cervical adenocarcinomas. (pdf) J Natl Cancer Inst 2006 March 1;98(5):292-3.
Jeronimo J, Schiffman M. Colposcopy at a crossroads. (pdf) Am J Obstet Gynecol 2006 May 2;Available at: URL: PM:16677597.
Schiffman M, Castle PE. When to test women for human papillomavirus. (pdf) BMJ 2006 January 14;332(7533):61-2.
Sherman ME, Carreon JD, Schiffman M. Performance of cytology and human papillomavirus testing in relation to the menstrual cycle. (pdf) Br J Cancer 2006 Jun 5;94(11):1690-6.
Castle PE, Solomon D, Schiffman M, Wheeler CM. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. (pdf) J Natl Cancer Inst 2005 July 20;97(14):1066-71.
Schiffman M, Herrero R, Desalle R et al. The carcinogenicity of human papillomavirus types reflects viral evolution. (pdf) Virology 2005 June 20;337(1):76-84.
Schiffman M, Castle PE. The promise of global cervical-cancer prevention. (pdf) N Engl J Med 2005 November 17;353(20):2101-4.
Wang SS, Walker JL, Schiffman M, Solomon D. Evaluating the risk of cervical precancer with a combination of cytologic, virologic, and visual methods. (pdf) Cancer Epidemiol Biomarkers Prev 2005 November;14(11):2665-8.

Brinton LA, Lacey JV Jr, Trimble EL. Hormones and endometrial cancer-new data from the Million Women Study. (pdf) (Comment on "Endometrial cancer and hormone replacement therapy in the Million Women Study"). Lancet 2005;365:1517-8.
Brinton LA, Sakoda LC, Sherman ME et al. Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. (pdf) Cancer Epidemiol Biomarkers Prev 2005 December;14(12):2929-35.
Brinton LA, Westhoff CL, Scoccia B et al. Causes of infertility as predictors of subsequent cancer risk. Epidemiology 2005 July;16(4):500-7. (pdf, 301kb)
Lacey JV Jr, Brinton LA, Lubin JH, Sherman ME, Schatzkin A, Schairer C. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women. (pdf) Cancer Epidemiol Biomarkers Prev 2005 July;14(7):1724-31.
Sherman ME, Carreon JD, Lacey JV Jr, Devesa SS. Impact of hysterectomy on endometrial carcinoma rates in the United States. (pdf) J Natl Cancer Inst 2005;97(2):1700-2.
Brinton LA, Lubin JH, Murray MC, Colton T, Hoover RN. Mortality rates among augmentation mammoplasty patients: An update. (pdf) Epidemiology 2006 March;17(2):162-9.

McGlynn KA, Graubard BI, Nam JM, Stanczyk FZ, Longnecker MP, Klebanoff MA. Maternal hormone levels and risk of cryptorchism among populations at high and low risk of testicular germ cell tumors. (pdf) Cancer Epidemiol Biomarkers Prev 2005 July;14(7):1732-7.
Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. (pdf) Front Biosci 2006 May 1;11:1388-413.
Hsing AW, Chua S Jr, Gao Y-T, Deng J, Stanczyk FZ. Insulin resistance and prostate cancer risk. (pdf) J Natl Cancer Inst 2003;95(1):67-71.